Concerns about Patient Access to Biopharmaceuticals and Outcomes

HKS Affiliated Authors

Ethel Zimmerman Wiener Professor of Public Policy, HKS; Henry and Allison McCance Professor of Business Administration, HBS

Excerpt

January 18, 2023, Paper: "A survey of the NEJM Catalyst Insights Council finds strong support globally for government regulation of biopharmaceutical prices."

In This Section

HKS Affiliated Authors

Excerpt

Matthew Baum on the Rise of Misinformation

What Should Be Clinicians’ Roles in Regulatory Assessment of Prospective Interventions’ Risks of Exacerbating Inequity?

Study finds vertical integration in medicine is leading to higher costs and worse health outcomes